Medline Inc.
MDLN
$41.46
$0.390.95%
NASDAQ
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 182.00M | 322.00M | 327.50M | 327.50M | 289.00M |
| Total Depreciation and Amortization | 261.00M | 253.00M | 248.50M | 248.50M | 253.00M |
| Total Amortization of Deferred Charges | 14.00M | 15.00M | 15.00M | 15.00M | 15.00M |
| Total Other Non-Cash Items | 54.00M | 45.00M | 99.50M | 99.50M | 50.00M |
| Change in Net Operating Assets | -282.00M | 1.00M | -251.00M | -251.00M | -680.00M |
| Cash from Operations | 229.00M | 636.00M | 439.50M | 439.50M | -73.00M |
| Capital Expenditure | -138.00M | -101.00M | -120.50M | -120.50M | -91.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 3.00M | 3.00M | -6.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -138.00M | -101.00M | -117.50M | -117.50M | -97.00M |
| Total Debt Issued | 0.00 | 7.57B | 89.50M | 89.50M | 6.29B |
| Total Debt Repaid | -4.09B | -7.59B | -99.00M | -99.00M | -6.31B |
| Issuance of Common Stock | 7.05B | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.97B | -18.00M | -7.50M | -7.50M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -96.00M | -119.00M | -151.50M | -151.50M | -1.36B |
| Other Financing Activities | -- | -- | -- | -- | -8.00M |
| Cash from Financing | 897.00M | -161.00M | -168.50M | -168.50M | -1.39B |
| Foreign Exchange rate Adjustments | -1.00M | -3.00M | 13.50M | 13.50M | -2.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 987.00M | 371.00M | 167.00M | 167.00M | -1.57B |